View our webinar on "PTAB Trials by the Numbers"

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

View our webinar on "PTAB Trials by the Numbers"

Our next Managing IP webinar is taking place on Tuesday June 14 and is titled “PTAB Trials by the Numbers”. Partners from Fitzpatrick Cella Harper & Scinto will provide a statistical analysis of inter partes review and covered business method trials at the Patent Trial and Appeal Board

*UPDATE: The webinar has now taken place. View a replay here or below*   

Join me for our next webinar, “PTAB Trials by the Numbers”.

The webinar takes place on Tuesday June 14 at 11am (New York), 8am (West Coast), 4pm (London).

Presenters:

Justin Oliver and Jonathan Berschadsky – partners at Fitzpatrick Cella Harper & Scinto,

Moderator:

Michael Loney – Americas editor at Managing IP

The webinar will feature a statistical analysis of inter partes review (IPR) and covered business method (CBM) trials at the Patent Trial and Appeal Board. The analysis will avoid pitfalls that obscure the true picture of PTAB proceedings and will address how the statistics should shape your PTAB trial strategies.


This webinar will cover topics including: 

• A dive into PTAB statistics

• Overall success rates, on a claim by claim basis

• Comparisons of success rates for statutory grounds 

• Trends in institution rates

• Comparisons to district court success rates

• Differences in technology areas

• The likely reasons behind the numbers

• A glimpse into the future 

As with all our webinars, there will also be an opportunity for the audience to ask questions of the panellists.

The webinar is free to attend: just register here and join us on Tuesday. 



more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article